Merit Medical [MMSI] vs Becton, Dickinson [BDX] Detailed Stock Comparison
Merit Medical
Becton, Dickinson
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Merit Medical wins in 7 metrics, Becton, Dickinson wins in 12 metrics, with 0 ties. Becton, Dickinson appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Merit Medical | Becton, Dickinson | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 41.98 | 34.63 | Becton, Dickinson |
| Price-to-Book Ratio | 3.29 | 2.13 | Becton, Dickinson |
| Debt-to-Equity Ratio | 55.14 | 75.93 | Merit Medical |
| PEG Ratio | -4.27 | 1.82 | Merit Medical |
| EV/EBITDA | 19.09 | 12.30 | Becton, Dickinson |
| Profit Margin (TTM) | 8.31% | 7.41% | Merit Medical |
| Operating Margin (TTM) | 12.30% | 17.81% | Becton, Dickinson |
| EBITDA Margin (TTM) | 12.30% | 17.81% | Becton, Dickinson |
| Return on Equity | 8.60% | 6.18% | Merit Medical |
| Return on Assets (TTM) | 4.19% | 3.96% | Merit Medical |
| Free Cash Flow (TTM) | $182.76M | $3.07B | Becton, Dickinson |
| Dividend Yield | N/A | 1.80% | N/A |
| 1-Year Return | -12.58% | -21.12% | Merit Medical |
| Price-to-Sales Ratio (TTM) | 3.42 | 2.53 | Becton, Dickinson |
| Enterprise Value | $5.38B | $72.78B | Becton, Dickinson |
| EV/Revenue Ratio | 3.75 | 3.40 | Becton, Dickinson |
| Gross Profit Margin (TTM) | 48.24% | 47.81% | Merit Medical |
| Revenue per Share (TTM) | $24 | $74 | Becton, Dickinson |
| Earnings per Share (Diluted) | $1.97 | $5.46 | Becton, Dickinson |
| Beta (Stock Volatility) | 0.58 | 0.28 | Becton, Dickinson |
Merit Medical vs Becton, Dickinson Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Merit Medical | -4.23% | -6.20% | -11.04% | -17.00% | -13.71% | -17.78% |
| Becton, Dickinson | -1.33% | -3.64% | -0.99% | 5.10% | -6.31% | -17.63% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Merit Medical | -12.58% | 50.73% | 72.37% | 241.25% | 544.88% | 586.76% |
| Becton, Dickinson | -21.12% | -16.97% | -19.31% | 37.02% | 151.19% | 271.86% |
News Based Sentiment: Merit Medical vs Becton, Dickinson
Merit Medical
News based Sentiment: MIXED
October brought a significant leadership change alongside strong Q2 earnings and a stock price decline, creating a mixed investment narrative. While the company demonstrates positive financial momentum and technological advancements, the stock's performance and insider selling introduce uncertainty, making this a moderately important month for investors.
Becton, Dickinson
News based Sentiment: POSITIVE
BD delivered a strong Q3 performance with earnings and revenue exceeding expectations, leading to raised guidance. Strategic partnerships, particularly with Opentrons, and continued investment in manufacturing demonstrate a commitment to future growth. While insider selling and a slight revenue outlook revision exist, the overall narrative is positive, supported by robust institutional investment.
Performance & Financial Health Analysis: Merit Medical vs Becton, Dickinson
| Metric | MMSI | BDX |
|---|---|---|
| Market Information | ||
| Market Cap | $4.96B | $53.47B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 669,400 | 1,308,870 |
| 90 Day Avg. Volume | 683,753 | 1,517,590 |
| Last Close | $78.99 | $186.56 |
| 52 Week Range | $78.12 - $111.45 | $163.33 - $251.99 |
| % from 52W High | -29.13% | -25.97% |
| All-Time High | $111.45 (Jan 27, 2025) | $287.32 (Jul 24, 2023) |
| % from All-Time High | -29.13% | -35.07% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.13% | 0.10% |
| Quarterly Earnings Growth | -0.09% | 0.18% |
| Financial Health | ||
| Profit Margin (TTM) | 0.08% | 0.07% |
| Operating Margin (TTM) | 0.12% | 0.18% |
| Return on Equity (TTM) | 0.09% | 0.06% |
| Debt to Equity (MRQ) | 55.14 | 75.93 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $25.13 | $88.87 |
| Cash per Share (MRQ) | $5.77 | $2.64 |
| Operating Cash Flow (TTM) | $239.96M | $3.25B |
| Levered Free Cash Flow (TTM) | $190.72M | $3.37B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.80% |
| Last 12-Month Dividend | N/A | $3.03 |
Valuation & Enterprise Metrics Analysis: Merit Medical vs Becton, Dickinson
| Metric | MMSI | BDX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 41.98 | 34.63 |
| Forward P/E | 22.29 | 12.02 |
| PEG Ratio | -4.27 | 1.82 |
| Price to Sales (TTM) | 3.42 | 2.53 |
| Price to Book (MRQ) | 3.29 | 2.13 |
| Market Capitalization | ||
| Market Capitalization | $4.96B | $53.47B |
| Enterprise Value | $5.38B | $72.78B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.75 | 3.40 |
| Enterprise to EBITDA | 19.09 | 12.30 |
| Risk & Other Metrics | ||
| Beta | 0.58 | 0.28 |
| Book Value per Share (MRQ) | $25.13 | $88.87 |
Financial Statements Comparison: Merit Medical vs Becton, Dickinson
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | MMSI | BDX |
|---|---|---|
| Revenue/Sales | $355.35M | $5.51B |
| Cost of Goods Sold | $183.33M | $2.88B |
| Gross Profit | $172.02M | $2.63B |
| Research & Development | $22.48M | $297.00M |
| Operating Income (EBIT) | $42.06M | $979.00M |
| EBITDA | $77.83M | $1.57B |
| Pre-Tax Income | $37.96M | $703.00M |
| Income Tax | $7.81M | $129.00M |
| Net Income (Profit) | $30.15M | $574.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | MMSI | BDX |
|---|---|---|
| Cash & Equivalents | $395.53M | $667.00M |
| Total Current Assets | $958.64M | $8.67B |
| Total Current Liabilities | $196.82M | $7.69B |
| Long-Term Debt | $808.22M | $17.67B |
| Total Shareholders Equity | $1.43B | $25.24B |
| Retained Earnings | $725.69M | $16.15B |
| Property, Plant & Equipment | $432.99M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | MMSI | BDX |
|---|---|---|
| Operating Cash Flow | $57.24M | $941.00M |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | $19.05M | $35.00M |
| Debt Repayment | $0 | $-1.00M |
| Common Stock Repurchase | N/A | $0 |
Short Interest & Institutional Ownership Analysis
| Metric | MMSI | BDX |
|---|---|---|
| Shares Short | 3.22M | 3.83M |
| Short Ratio | 5.91 | 2.40 |
| Short % of Float | 0.08% | 0.01% |
| Average Daily Volume (10 Day) | 669,400 | 1,308,870 |
| Average Daily Volume (90 Day) | 683,753 | 1,517,590 |
| Shares Outstanding | 58.74M | 289.10M |
| Float Shares | 57.79M | 286.00M |
| % Held by Insiders | 0.02% | 0.01% |
| % Held by Institutions | 1.08% | 0.92% |
Dividend Analysis & Yield Comparison: Merit Medical vs Becton, Dickinson
| Metric | MMSI | BDX |
|---|---|---|
| Last 12-Month Dividend | N/A | $3.03 |
| Last 12-Month Dividend Yield | N/A | 1.80% |
| 3-Year Avg Annual Dividend | N/A | $3.16 |
| 3-Year Avg Dividend Yield | N/A | 0.40% |
| 3-Year Total Dividends | N/A | $9.48 |
| Ex-Dividend Date | N/A | Mar 10, 2025 |